
AI-Designed Viruses Reach a First Patient While Biotech Funding Tightens, and the Verified Numbers Point to Who Can Wait
Radical Numerics says AI-designed viruses have treated its first patient, but the claim comes from a low-reliability source. SEC-checked Incyte cash data and company guidance show runway and partnerships matter more than AI in a risk-off market.



















